Exporter Supply Landscape

Supplier countries for (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)

A reported trade view for HS 300390, with available observations through 2024.

HS6 300390Coverage 1995-2024Updated 2026-08-14
Explore this product

Leading supplier

Portugal$1.6B

Supplier countries

198Reported suppliers

Top supplier reach

45Destination markets

Latest global trade

$10.9BYear: 2024

Reported observations

Supplier evidence

Supplier countries ranked by latest reported export value.

SupplierLatest exports5-year growthDestinationsLeading destination
Portugal$1.6B+57%45USA
USA$1.6B+7.8%131Germany
Ireland$905.2M+35.8%61Portugal
Switzerland, Liechtenstein$849.9M+7.5%98Spain
Germany$764.6M-0.8%99Ireland
China$519.5M+9.7%139India
Belgium$496.5M+21.1%109Germany
Italy$495.9M+18.1%97Netherlands
Spain$470.8M+10%79Germany
France$466.2M+7.6%120Japan
India$421.8M+5%179USA
Singapore$349.9M+20.5%40USA
Netherlands$340.0M-32.9%95Ireland
Japan$154.2M+5.4%46China
Austria$138.3M+37.3%54Italy
Sweden$136.2M-2.9%37China
Slovenia$123.3M+2.6%30Russia
United Kingdom$108.9M-5%113Germany
Denmark$92.1M-2.6%57Portugal
Jordan$87.9M-13.5%48Saudi Arabia
Czechia$78.5M+0.1%35Slovakia
Canada$78.4M-2.3%68USA
Hungary$78.0M-0.6%28Poland
Republic of Korea$69.2M+5.4%69USA
Australia$55.2M+7.4%59Hungary
Saudi Arabia$53.1M+34.6%16United Arab Emirates
Israel$51.4M-33.3%26USA
Poland$47.8M+4.8%44Spain
Greece$36.9M+6.2%51Germany
Romania$26.4M+27.5%29Bulgaria
Norway$23.9M-14.9%22Japan
Croatia$23.4M+13.8%17Spain
Bulgaria$22.4M+12.2%27Netherlands
Russia$20.8M-11.4%11Belarus
South Africa$17.5M+1.3%73China

Market reading

Which countries supply (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)?

Portugal is the leading reported supplier in this view, with exports of $1.6B.

How to use this view

Start with the leading rows in the first table, then use the chart to compare supplier scale and destination reach for (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale). The second table adds a related reported comparison.

Coverage extends to 2024. Missing values are shown as not reported.

Further comparison

Supplier corridor unit-value evidence

Reported corridor unit values for the selected supplier, compared with each buyer market's median.

Buyer marketReported yearTrade valueQuantityUnit value USD/tonBuyer-market median USD/ton
USA2023$1.1B27.1 t$40,792,303.99$40,500
Ireland2023$41.3M10.3 t$3,993,148.35$104,626.25
Switzerland, Liechtenstein2023$35.9M1.2 t$31,141,008.68$133,500
United Kingdom2023$16.0M79.8 t$200,270.77$118,923.88
Republic of Korea2023$11.5M29.9 t$384,331.84$71,072.56
Jordan2023$8.2M234 t$35,007.06$58,782.3
Saudi Arabia2023$3.3M92 t$35,761.17$175,041
Spain2023$2.6M234.6 t$11,234.17$79,000
Germany2023$2.2M33.4 t$65,293.26$62,200
Czechia2023$1.8M8.6 t$211,955.9$156,499.57
Poland2023$1.6M37.9 t$41,985.68$70,927.64
Hungary2023$986.9K7.7 t$127,517.12$48,416.11
France2023$920.8K21.2 t$43,438.03$22,528.38
Belgium2023$629.6K2.4 t$267,585.21$116,000
Denmark2023$547.8K2 t$267,481.93$59,055.61
Indonesia2023$543.2K4.6 t$118,941.76$82,358.08
Algeria2023$349.8K3.6 t$98,107.71$61,192.65
Netherlands2023$297.4K7.9 t$37,592.04$40,003.71
Tunisia2023$286.5K1.5 t$189,215.32$172,720.43
Sweden2023$225.2K0.6 t$395,787.35$213,276.03

Explore related views

Continue with another perspective on this product.

Latest observed year: 2024. Page updated 2026-08-14.

Source and date

Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.

Definitions

Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.

Reading the data

“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.